16:01 Apr 09

Vanta Bioscience Ltd.

Sector Diversified Consumer Services Industry Healthcare Services
Up
20.92
+0.98 (+4.91%)
Sector Diversified Consumer Services Industry Healthcare Services

Vanta Bioscience Ltd.

Sector Diversified Consumer Services
Industry Healthcare Services
Up
20.92
+0.98 (+4.91%)
16:01 Apr 09
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

27/100
Expensive Valuation

Technical

19/100
Technically Bearish

Strength

4

Weakness

9

Opportunity

0

Threats

0

13.20

Market Cap (Cr)

-

PE Ratio

0.83

Price to Book Ratio

27.94

RSI

-23.81 %

Net Profit Margin

News

Announcement

  • 29 Mar 2025

    Closure of Trading Window

    Closure of Trading Window

  • 06 Sep 2024

    AGM On 30.09.2024

    AGM on 30.09.2024

  • 06 Sep 2024

    Board Meeting Outcome for Outcome Of Board Meeting Held On 06.09.2024 - 8Th Annual General Meeting T

    Outcome of Board Meeting held on 06.09.2024 - Reappointment of Independent Directors Secretarial & Internal Auditors and regarding 8th AGM of the Company

  • 06 Sep 2024

    Reg. 34 (1) Annual Report.

    Annual Report for FY 2023-24

  • 18 Aug 2024

    Intimation Of Submission Of Application To BSE For Reclassification From Promoter Category To Public

    Intimation of submission of application to BSE for reclassification from Promoter to Public Category

  • 24 Jul 2024

    Regulation 30 - Submission Of Resignation Letters Of Directors Dated 19.07.2024

    Submission of resignation letters of Directors dated 19.07.2024 pursuant to Regulation 30 of SEBI (LODR) Regulations 2015

  • 20 Jul 2024

    Approval Of Board For Reclassification Of 2 Promoters To Public Category

    Approval of Board for reclassification of 2 Promoters to Public Category

  • 20 Jul 2024

    Approval Of Board For Reclassification Of 2 Promoters To Public Category

    Approval of Board for reclassification of 2 Promoters to Public Category

  • 19 Jul 2024

    Results For The Period Ended 31.03.2024

    Results for the period ended 31.03.2024

  • 19 Jul 2024

    Board Meeting Outcome for Outcome Of Board Meeting Held On 19.07.2024

    Outcome of Board Meeting held on 19.07.2024

  • 17 Jul 2024

    Board Meeting Intimation for Intimation Regarding Postponement Of Board Meeting To 19.07.2024 For Ap

    Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/07/2024 inter alia to consider and approve the Standalone and Consolidated financial results of the Company for the half year and year ended 31.03.2024 and... More>

  • 10 Jul 2024

    Board Meeting Intimation for Approval Of Financial Results For The Half Year And Year Ended 31.03.20

    Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/07/2024 inter alia to consider and approve the financial results for the half year and year ended 31.03.2024

  • 21 Apr 2024

    Compliance Certificate Under Regulation 40(9)

    Compliance Certificate under Regulation 40(9)

  • 21 Apr 2024

    Reg. 34 (1) Annual Report.

    Annual Report for FY 2021-22

  • 21 Apr 2024

    Compliance Certificate Under Regulation 7(3)

    Compliance Certificate under Regulation 7(3)

  • 02 Apr 2024

    Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    Receipt of order worth Rs. 1.2 Cr for technical studies

  • 01 Apr 2024

    Appointment of Company Secretary and Compliance Officer

    Appointment of CS and Compliance Officer w.e.f 01.04.2024

qr-code
login-icon

Take your research to the next level.
Login now to unlock Exclusive Features!

login-icon-1

Take your research to the next level.
Login now to unlock Exclusive Features!

Download Our App On:

SunMonTueWedThuFriSat
2627282930311234567891011121314151617181920212223242526272829303112345